2244 -- Patient Experience in Research Act of 2017 | Poliscope

Patient Experience in Research Act of 2017

2244

115th Congress

Health

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

April 28, 2017

Latest Action

May 5, 2017

Primary Sponsor

Leonard LanceRepublican(NJ)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

52pct

7d open

vs 7,393 other HR bills in the 115th — cohort avg 50d

Summary

Patient Experience in Research Act of 2017 This bill requires the Food and Drug Administration to carry out a pilot project under which sponsors of new drugs or biological products agree to evaluate: (1) the distress experienced by patients in clinical trials for medications intended to treat a serious condition, and (2) the effects of providing support to distressed patients on the outcome of a clinical trial. The user fee is waived for new drug applications that include data from such an evaluation.

Lobbying filings that explicitly cite this bill (1)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (1)

CAMERON KRIER MASSEY, INC. DBA SCOUT GR (1)

LIVESTRONG FOUNDATIONclient→CAMERON KRIER MASSEY, INC. DBA SCOUT GR

2017 · second_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Deferment for Active Cancer Treatment Act of 2017 (HR 2976), To amend the Higher Education Act of 1965 to allow for the deferment of certain student loans during a period in which a borrower is receiving treatment for cancer. American Health Care Act (HR 1628) and Better Care Reconciliation Act, provisions related to loss of insurance, increased health insurance premiums, reductions to Medicaid funding, and those negatively impacting access to care for cancer patients/survivors. The Patient Experience in Research Act of 2017 (HR 2244 ), directs the Secretary of Health of and Human Services to carry out a pilot project under which no more than three sponsors agree to evaluate the psychological and social distress experienced by patients participating in a clinical trial.